Yekta Altemur Karamustafaoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yekta Altemur Karamustafaoglu has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Yener Yoruk
Department of Thoracic Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey
23 shared publications - Fazlı Yanık
Department of Thoracic Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey
11 shared publications Fazlı Yanık
Trakya Univ, Dept Thorac Surg, Edirne, Turkiye
3 shared publicationsMustafa Kuzucuoglu
Trakya University Faculty of Medicine, Department of Thoracic Surgery, Edirne, Turkey
3 shared publicationsTaner Tarladacalisir
Department of Thoracic Surgery, Bitlis State Hospital, Bitlis, Turkey
3 shared publicationsYener Yörük
Trakya Univ, Dept Thorac Surg, Edirne, Turkiye
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Wolters Kluwer Health in Nigerian Journal of Clinical Practice
- Vol. 29 (9) , 1070-1078
Comparıson of On-Q Intercostal Elastomerıc Pump System and Intravenous Analgesıa Methods for Paın Management after Thoracotomy
Background: Thoracotomy has been defined as one of the most painful surgical procedures. Inadequate pain control increases morbidity, hospital costs, and hospital length of stay. Aim: We aimed to compare the results of continuous infusion of local anesthetics through an intercostal On-Q (ICOQ) elastomeric pump under the pleura or intravenous analgesia to manage post-thoracotomy pain. Methods: We performed a prospective comparative analysis of 149 consecutive patients who underwent anterolateral thoracotomy between January 2018 and October 2021. Postoperative pain management with a continuous infusion elastomeric pump providing local anesthetic into the intercostal area was compared with intravenous analgesia. Patients received either the ICOQ elastomeric pump system (n = 73) or intravenous analgesia (n = 76) for the first 48 postoperative hours. Visual Analog Scale (VAS) rescue patient-controlled analgesia morphine consumption, hemodynamic, and side effects were evaluated within 48 hours. Results: The VAS scores of the IV group at 1, 4, 12, 24, 36, and 48 hours were statistically significantly higher than the On-Q group. ( P = 0.028, P = 0.041, P = 0.011, P = 0.001, P = 0.021, P = 0.017, respectively postoperative complications occurred in 17 (23%) patients in the ICOQ group, and 34 (45%) patients in the IV group. There was no significant difference between the two groups in terms of postoperative complications except for nausea and vomiting. Conclusion: Continuous analgesia using the ICOQ is an effective analgesia method for postoperative pain control for thoracotomy procedures that reduces pain scores and additional opioid consumption.
- 30 September 2026
- Published by Wolters Kluwer Health in Nigerian Journal of Clinical Practice
- Vol. 29 (9) , 1070-1078
Open AccessComparıson of On-Q Intercostal Elastomerıc Pump System and Intravenous Analgesıa Methods for Paın Management after Thoracotomy
Background: Thoracotomy has been defined as one of the most painful surgical procedures. Inadequate pain control increases morbidity, hospital costs, and hospital length of stay. Aim: We aimed to compare the results of continuous infusion of local anesthetics through an intercostal On-Q (ICOQ) elastomeric pump under the pleura or intravenous analgesia to manage post-thoracotomy pain. Methods: We performed a prospective comparative analysis of 149 consecutive patients who underwent anterolateral thoracotomy between January 2018 and October 2021. Postoperative pain management with a continuous infusion elastomeric pump providing local anesthetic into the intercostal area was compared with intravenous analgesia. Patients received either the ICOQ elastomeric pump system (n = 73) or intravenous analgesia (n = 76) for the first 48 postoperative hours. Visual Analog Scale (VAS) rescue patient-controlled analgesia morphine consumption, hemodynamic, and side effects were evaluated within 48 hours. Results: The VAS scores of the IV group at 1, 4, 12, 24, 36, and 48 hours were statistically significantly higher than the On-Q group. ( P = 0.028, P = 0.041, P = 0.011, P = 0.001, P = 0.021, P = 0.017, respectively postoperative complications occurred in 17 (23%) patients in the ICOQ group, and 34 (45%) patients in the IV group. There was no significant difference between the two groups in terms of postoperative complications except for nausea and vomiting. Conclusion: Continuous analgesia using the ICOQ is an effective analgesia method for postoperative pain control for thoracotomy procedures that reduces pain scores and additional opioid consumption.
- 4 April 2026
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (7) , 3189-3196
Segmentectomy or Lobectomy in T1N0M0 Non-Small Cell Lung Carcinomas: The Prognostic Role of Histology and Vascular Invasion
- 4 April 2026
- Published by Springer Nature in Updates in Surgery
- Vol. 78 (7) , 3189-3196
Segmentectomy or Lobectomy in T1N0M0 Non-Small Cell Lung Carcinomas: The Prognostic Role of Histology and Vascular Invasion
- 19 March 2026
- Published by Wolters Kluwer Health in Journal of Minimal Access Surgery
Awake giant bullectomy with uniportal video-assisted thoracoscopic surgery
Giant bullous lung disease presents unique challenges in thoracic surgery due to the large size of bullae and compromised respiratory function. This case report highlights the successful use of awake uniportal video-assisted thoracoscopic surgery (A-UVATS) in a high-risk patient with severe chronic obstructive pulmonary disease and a giant multiseptated bulla occupying the entire left lower lobe. Instead of traditional general anaesthesia, regional techniques, including thoracic paravertebral block and dexmedetomidine sedation, were employed to ensure safety and comfort. The procedure resulted in significant clinical improvement, with minimal complications, aside from a transient air leak. Post-operative recovery was uneventful, and lung re-expansion was confirmed via imaging. This case highlights the feasibility and safety of A-UVATS bullectomy in carefully selected patients, offering improved recovery and reduced perioperative risks. More research is needed to develop standardised protocols and evaluate long-term outcomes of awake thoracic surgical approaches.
- 19 March 2026
- Published by Wolters Kluwer Health in Journal of Minimal Access Surgery
Awake giant bullectomy with uniportal video-assisted thoracoscopic surgery
Giant bullous lung disease presents unique challenges in thoracic surgery due to the large size of bullae and compromised respiratory function. This case report highlights the successful use of awake uniportal video-assisted thoracoscopic surgery (A-UVATS) in a high-risk patient with severe chronic obstructive pulmonary disease and a giant multiseptated bulla occupying the entire left lower lobe. Instead of traditional general anaesthesia, regional techniques, including thoracic paravertebral block and dexmedetomidine sedation, were employed to ensure safety and comfort. The procedure resulted in significant clinical improvement, with minimal complications, aside from a transient air leak. Post-operative recovery was uneventful, and lung re-expansion was confirmed via imaging. This case highlights the feasibility and safety of A-UVATS bullectomy in carefully selected patients, offering improved recovery and reduced perioperative risks. More research is needed to develop standardised protocols and evaluate long-term outcomes of awake thoracic surgical approaches.
- 25 July 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (12) , 4000-4002
Prımary Esophageal Extranodal Margınal Zone Lymphoma: A Rare Tumor
- 25 July 2025
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 70 (12) , 4000-4002
Prımary Esophageal Extranodal Margınal Zone Lymphoma: A Rare Tumor
- 5 November 2024
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (6) , 2750-2760
Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis
Purpose This study aimed to investigate the impact of oligometastasis and the M descriptor on survival in small cell lung cancer (SCLC). Methods This multicenter, retrospective study included patients with newly diagnosed extensive-stage SCLC(ES-SCLC) from 2010 to 2020. Subgroups: Group 1: single metastasis in a single organ, Group 2: 2–5 metastases in a single organ, Group 3: 6 or more metastases in a single organ, and Group 4: metastases in two or more organs. This classification was based on the 9th Staging-M descriptor. Three-year progression-free survival (PFS) and overall survival (OS) analyses were conducted. Results The mean age of the 439 patients was 62 ± 10 years, and 89.5% of them were male. The mean PFS for Groups 1, 2, 3, 4 was 10.7 months (95% CI 8.9–12.5), 7.5 months (95% CI 5.6–9.4), 4.3 months (95% CI 2.9–5.7), and 5.4 months (95% CI 4.7–6.1), respectively. PFS in Group 2 was significantly higher. The mean OS for Groups 1, 2, 3, 4 was 13.3 months (95% CI 11.2–15.3), 9.5 months (95% CI 7.1–11.9), 7.1 months (95% CI 4.5–9.7), and 6.9 months (95% CI 6.0–7.9), respectively. OS in Group 1 was significantly higher. OS and PFS in the M1b group were significantly higher than in the M1c1 and M1c2 groups (p < 0.05) with no statistical difference between the M1c1 and M1c2 groups. Conclusion There is no significant difference in survival between the M1c1 and M1c2 groups. In ES-SCLC, the number of metastases may be a more predictive factor for prognosis than the number of metastatic organs.
- 5 November 2024
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 27 (6) , 2750-2760
Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis
Purpose This study aimed to investigate the impact of oligometastasis and the M descriptor on survival in small cell lung cancer (SCLC). Methods This multicenter, retrospective study included patients with newly diagnosed extensive-stage SCLC(ES-SCLC) from 2010 to 2020. Subgroups: Group 1: single metastasis in a single organ, Group 2: 2–5 metastases in a single organ, Group 3: 6 or more metastases in a single organ, and Group 4: metastases in two or more organs. This classification was based on the 9th Staging-M descriptor. Three-year progression-free survival (PFS) and overall survival (OS) analyses were conducted. Results The mean age of the 439 patients was 62 ± 10 years, and 89.5% of them were male. The mean PFS for Groups 1, 2, 3, 4 was 10.7 months (95% CI 8.9–12.5), 7.5 months (95% CI 5.6–9.4), 4.3 months (95% CI 2.9–5.7), and 5.4 months (95% CI 4.7–6.1), respectively. PFS in Group 2 was significantly higher. The mean OS for Groups 1, 2, 3, 4 was 13.3 months (95% CI 11.2–15.3), 9.5 months (95% CI 7.1–11.9), 7.1 months (95% CI 4.5–9.7), and 6.9 months (95% CI 6.0–7.9), respectively. OS in Group 1 was significantly higher. OS and PFS in the M1b group were significantly higher than in the M1c1 and M1c2 groups (p < 0.05) with no statistical difference between the M1c1 and M1c2 groups. Conclusion There is no significant difference in survival between the M1c1 and M1c2 groups. In ES-SCLC, the number of metastases may be a more predictive factor for prognosis than the number of metastatic organs.
- 1 January 2024
- Published by Kare Publishing in Eurasian Journal of Pulmonology
- Vol. 26 (3) , 210-213
A case of primary B-cell thyroid lymphoma with extensive tracheal invasion
Primary thyroid lymphoma (PTL) is a rare malignancy originating in the thyroid gland. It can manifest as a rapidly growing mass within the mediastinum, potentially compressing the trachea and causing respiratory difficulties. Diagnosing PTL can be challenging due to its rarity, impacting the available treatment options. The choice of surgical intervention depends on the location, depth, and extent of the invasion. If the tumor has penetrated the tracheal mucosa, then complete removal is required, but this may result in serious complications. Here, we report a distinctive case of PTL involving the trachea, and further complicated by severe airway obstruction and perforation.
- 1 January 2024
- Published by Kare Publishing in Eurasian Journal of Pulmonology
- Vol. 26 (3) , 210-213
A case of primary B-cell thyroid lymphoma with extensive tracheal invasion
Primary thyroid lymphoma (PTL) is a rare malignancy originating in the thyroid gland. It can manifest as a rapidly growing mass within the mediastinum, potentially compressing the trachea and causing respiratory difficulties. Diagnosing PTL can be challenging due to its rarity, impacting the available treatment options. The choice of surgical intervention depends on the location, depth, and extent of the invasion. If the tumor has penetrated the tracheal mucosa, then complete removal is required, but this may result in serious complications. Here, we report a distinctive case of PTL involving the trachea, and further complicated by severe airway obstruction and perforation.
- Open Access
- 1 January 2024
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 23 (1) , 83-88
Evaluation of Chrisofix® Chest Orthosis Application in Patients with Traumatic Rib Fractures
Background: The Chrisofix® Chest Orthosis is an effective and easy to use device for the treatment of rib fractures. It is used as a supportive treatment to reduce the pain levels and complication risks of the patients. Methods: Patients hospitalized with the diagnosis of rib fractures in the Thoracic Surgery Service of a university hospital were retrospectively scanned in an online computer program between October 2018 and October 2021. The study sample consisted of patients with the treatment (30) and control (30) groups. Results: Visual Analog Scale and incidence of atelectasis of the patients in the experimental group (The Chrisofix® Chest Orthosis) is statistically significantly lower than the control group (P < 0.05). In both the experimental and control groups, no statistically significant difference was found between the variables of patient’s demographic and clinical characteristics (p > 0.05). Conclusions: In the study, with the use of The Chrisofix® Chest Orthosis, a significant decrease was observed in the Visual Analog Scale and the incidence of atelectasis. Bangladesh Journal of Medical Science Vol. 23 No. 01 January’24 Page : 83-88
- 1 January 2024
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Medical Science
- Vol. 23 (1) , 83-88
Open AccessEvaluation of Chrisofix® Chest Orthosis Application in Patients with Traumatic Rib Fractures
Background: The Chrisofix® Chest Orthosis is an effective and easy to use device for the treatment of rib fractures. It is used as a supportive treatment to reduce the pain levels and complication risks of the patients. Methods: Patients hospitalized with the diagnosis of rib fractures in the Thoracic Surgery Service of a university hospital were retrospectively scanned in an online computer program between October 2018 and October 2021. The study sample consisted of patients with the treatment (30) and control (30) groups. Results: Visual Analog Scale and incidence of atelectasis of the patients in the experimental group (The Chrisofix® Chest Orthosis) is statistically significantly lower than the control group (P < 0.05). In both the experimental and control groups, no statistically significant difference was found between the variables of patient’s demographic and clinical characteristics (p > 0.05). Conclusions: In the study, with the use of The Chrisofix® Chest Orthosis, a significant decrease was observed in the Visual Analog Scale and the incidence of atelectasis. Bangladesh Journal of Medical Science Vol. 23 No. 01 January’24 Page : 83-88
- Open Access
- 1 April 2023
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 31 (2) , 295-299
Wedge resection and pleurodesis through single-incision videothoracoscopic transmediastinal approach for bilateral spontaneous pneumothorax
In general, in cases of bilateral primary pneumothorax, videoassisted thoracoscopic surgery procedures are performed sequentially on both sides. However, there are only a few reported cases of bullectomy through video-assisted thoracoscopic surgery using a transmediastinal approach for bilateral primary spontaneous pneumothorax. A 20-year-old male patient was admitted to our clinic with a right pneumothorax and developed a left pneumothorax four days later while he was under treatment. He underwent bilateral bullectomy and pleurodesis via a singleincision video-assisted thoracoscopic surgery in the supine position. The patient was discharged uneventfully within 72 h after the procedure. In conclusion, bilateral bullectomy and pleurodesis using single-incision transmediastinal access video-assisted thoracoscopic surgery may be good choices that are technically reliable and provide favorable surgical outcomes.
- 1 April 2023
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 31 (2) , 295-299
Open AccessWedge resection and pleurodesis through single-incision videothoracoscopic transmediastinal approach for bilateral spontaneous pneumothorax
In general, in cases of bilateral primary pneumothorax, videoassisted thoracoscopic surgery procedures are performed sequentially on both sides. However, there are only a few reported cases of bullectomy through video-assisted thoracoscopic surgery using a transmediastinal approach for bilateral primary spontaneous pneumothorax. A 20-year-old male patient was admitted to our clinic with a right pneumothorax and developed a left pneumothorax four days later while he was under treatment. He underwent bilateral bullectomy and pleurodesis via a singleincision video-assisted thoracoscopic surgery in the supine position. The patient was discharged uneventfully within 72 h after the procedure. In conclusion, bilateral bullectomy and pleurodesis using single-incision transmediastinal access video-assisted thoracoscopic surgery may be good choices that are technically reliable and provide favorable surgical outcomes.
- Open Access
- 1 January 2023
- Published by Current Thoracic Surgery in Current Thoracic Surgery
- Vol. 8 (2) , 100
Abdominothoracic fistulas due to complicated echinococcosis: surgical treatment and outcome
Abdominothoracic fistulas due to complicated Echinococcosis: surgical treatment and outcome
- 1 January 2023
- Published by Current Thoracic Surgery in Current Thoracic Surgery
- Vol. 8 (2) , 100
Open AccessAbdominothoracic fistulas due to complicated echinococcosis: surgical treatment and outcome
Abdominothoracic fistulas due to complicated Echinococcosis: surgical treatment and outcome